Analysts have recently evaluated XOMA Royalty and provided 12-month price targets. The average target is $119.2, accompanied ...

H.C. Wainwright maintained a Buy rating on XOMA Ltd . (NASDAQ: NASDAQ:XOMA) but reduced the price target for the company's shares from $123.00 to $104.00. Currently trading at $26.61, the stock sits ...

H.C. Wainwright lowered the firm’s price target on Xoma (XOMA) to $104 from $123 and keeps a Buy rating on the shares. The firm removed ...

XOMA Co. (NASDAQ:XOMAO – Get Free Report) was the recipient of a significant drop in short interest in January. As of January 15th, there was short interest totalling 2,500 shares, a drop of 34.2% ...

Short XOMA slightly under 29.28, target 25.85, stop loss @ 29.36 Check the time stamp on this data. Updated AI-Generated ...

XOMA Royalty Corp (NASDAQ:XOMA), a $313 million market cap company, experienced a significant stock sale as reported in a recent SEC filing. Several major investors, including BVF Partners L.P., ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on XOMA stock, giving a Buy rating on January 7. Discover outperforming stocks and invest smarter with Top Smart Score ...

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA ...

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA ...

XOMA Royalty Corp. operates as a biotech royalty aggregator, which engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre ...